Micronized Purified Flavonoid Fraction（MPFF） ---A Bright New Star in the Future Medical Field

1. Antioxidant
MPFF has the ability to scavenge free radicals, which can help reduce cell damage and thus delay aging.

2. Anti-inflammatory
MPFF can regulate immune response, reduce tissue inflammation, and has a certain effect on relieving inflammatory diseases such as arthritis.

3. Lipid-lowering
MPFF can reduce blood lipid levels by inhibiting fat synthesis and promoting its decomposition, which can prevent the occurrence of cardiovascular diseases.

4. Inhibit platelet aggregation
MPFF can interfere with the adhesion and aggregation between platelets, thereby preventing thrombosis, which is beneficial for diseases such as stroke and myocardial infarction.

5. Improve blood circulation
MPFF can dilate blood vessels, increase blood flow, help lower blood pressure and improve heart function.

When using the above-mentioned products containing Micronized Purified Flavonoids Fraction, you should pay attention to possible allergic reactions and follow the guidance of doctors or professionals. At the same time, it should not be used as a substitute for traditional drug treatment. If you suffer from a specific disease, you should follow the doctor's advice for treatment.

In addition, Micronized Purified Flavonoids Fraction, are helpful in treating chronic venous insufficiency of the lower limbs.
International recognition: Micronized Purified Flavonoids Fraction has been used as venous active drugs in Europe and the United States for nearly 60 years, bringing therapeutic benefits to nearly 25 million patients with venous inflammation worldwide. This shows that the safety and effectiveness of this ingredient have been widely recognized internationally.
Alvenor is a Micronized Purified Flavonoids Fraction, a new drug composed of Diosmin and Desperdin. A large number of clinical trials using Alvenor on 133 patients with chronic venous insufficiency (CVI) have proved that Alvenor has a positive effect on CVI symptoms and signs.

Market demand and application scope
In recent years, with the deepening of research and the increase in market demand, the application scope of Micronized Purified Flavonoids Fraction has been continuously expanded. Its market demand mainly comes from the following aspects:
Treatment of chronic venous disease: Globally, nearly 25 million patients with venous inflammation benefit from this drug 3.
Treatment of hemorrhoids: In China, the number of hemorrhoid patients continues to increase due to the accelerated pace of life and increased work pressure. According to the new version of the hemorrhoid diagnosis and treatment guidelines, Micronized Purified Flavonoids Fraction is recommended as the preferred intravenous active drug for the treatment of patients with grade I-IV hemorrhoids3.

Status in clinical guidelines
Micronized Purified Flavonoids Fraction has a significant status in clinical guidelines, especially in the Chinese chronic venous disease diagnosis and treatment guidelines, and are recommended for all stages of CVD4. Its clinical benefits are mainly reflected in the comprehensive improvement of CVD symptoms and signs, improving quality of life, and shortening ulcer healing time.

In summary, the application prospects of Micronized Purified Flavonoids Fraction in the medical field are broad, the market demand continues to grow, and with the advancement of technology and the expansion of application scope, its future development prospects are worth looking forward to.